Olivier Gouédard, PharmD, MBA

Chief Operating Officer

Prior to joining Cytovia, Dr. Gouédard was Vice President, Global Cell Therapy Franchise at Bristol Myers Squibb, where he led the cross-functional development of CAR T cell therapies for multiple myeloma. Prior to Bristol Myers Squibb, he spent 8 years at Celgene as Executive Director, Global Project Leadership, leading global development teams for multiple early and late-stage assets in Hematology/Oncology and Inflammation/Immunology. Prior to his role at Celgene, Dr. Gouédard worked at Amgen where he advanced through positions in Finance, Project Management, Sales and Marketing.


Dr. Gouédard holds a Doctorate in Pharmacy from the University of Rennes I, France, an advanced degree in Experimental and Clinical Pharmacology from the Paris-Sud University, Paris, France, and an MBA in Finance/Accounting from the Stern School of Business, New York University.